对精神分裂症患者的临床药物坚持的审查
Fei Zhao1,2, Hua Zhong1,3, Pei-Pei Kang1,3
1Department of Gerontology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan 270000, Shandong Province, China.
World journal of psychiatry
|December 8, 2025
概括
改善精神分裂症患者的药物坚持对于症状管理和生活质量至关重要. 个性化,多方面的方法,包括创新的治疗方法和协作护理,是获得更好的结果的关键.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 精神分裂症的药物坚持对于治疗成功至关重要,但仍然是一个重大的全球挑战.
- 影响遵守的因素包括症状严重程度,患者的态度,社会支持和医疗保健沟通.
- 目前的评估方法,如自我报告有局限性;客观措施和生物标志物显示出希望.
研究的目的:
- 审查影响精神分裂症药物坚持的多方面的因素.
- 评估当前和新兴的方法来评估遵守.
- 探索改善这种患者群体的药物坚持的策略.
主要方法:
- 对关于精神分裂症药物坚持性的研究的文献综述.
- 分析各种评估工具,包括自我报告,电子监测和生物标志物.
- 检查诸如长效注射剂,心理治疗和多学科护理等干预措施.
主要成果:
- 与口服配方相比,长效注射抗精神病药物表现出更好的坚持性.
- 心理干预和多学科团队方法显著提高了患者的治疗结果.
- 创新的药物配方,数字健康技术和支持性政策是有希望的未来方向.
结论:
- 提高精神分裂症药物坚持需要个性化,综合战略.
- 医疗保健,政策和技术部门之间的协作努力对于最佳的临床和社会功能至关重要.
- 需要进一步的研究来解决与新合规技术相关的伦理,法律和隐私问题.
相关概念视频
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Psychosis and Antipsychotic Drugs: Overview
779
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
779
Psychosis: Goals of Pharmacotherapy
446
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
446
Psychological and Sociocultural Causes of Schizophrenia
450
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
450
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241


